Via: Brownstone Institute:
A series of revealing texts and tweets by Sam Bankman-Fried, the disgraced CEO of FTX, the once high-flying but now belly-up crypto exchange, had the following to say about his image as a do-gooder: it is a “dumb game we woke westerners play where we say all the right shibboleths and so everyone likes us.”
Very interesting. He had the whole game going: a vegan worried about climate change, supports every manner of justice (racial, social, environmental) except that which is coming for him, and shells out millions to worthy charities associated with the left. He also bought plenty of access and protection in D.C., enough to make his shady company the toast of the town.
As part of the mix, there is this thing called pandemic planning.
That’s right: there were deep connections between FTX and Covid that have been cultivated for two years. Let’s have a look.
Earlier this year, the New York Times trumpeted a study that showed no benefit at all to the use of Ivermectin. It was supposed to be definitive. The study was funded by FTX. Why? Why was a crypto exchange so interested in the debunking of repurposed drugs in order to drive governments and people into the use of patented pharmaceuticals, even those like Remdesivir that didn’t actually work? Inquiring minds would like to know.
David Henderson and Charles Hooper further point out an interesting fact: “Some of the researchers involved in the TOGETHER trial had performed paid services for Pfizer, Merck, Regeneron, and AstraZeneca, all companies involved in developing COVID-19 therapeutics and vaccines that nominally compete with ivermectin.”
For some reason, SBF just knew that he was supposed to oppose repurposed drugs, though he knew nothing about the subject at all. He was glad to fund a poor study to make it true and the New York Times played its assigned role in the whole performance.
It was just the start. A soft-peddling Washington Post investigation found that Sam and his brother Gabe, who ran a hastily founded Covid nonprofit, “have spent at least $70 million since October 2021 on research projects, campaign donations and other initiatives intended to improve biosecurity and prevent the next pandemic.”